Company Filing History:
Years Active: 2017
Title: Wesley Ralph Schaal: Innovator in Pharmaceutical Compounds
Introduction
Wesley Ralph Schaal is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target respiratory diseases and inflammation. His work is characterized by a focus on innovative solutions that address critical health issues.
Latest Patents
Wesley Ralph Schaal holds 1 patent for his invention titled "Compounds and uses." This patent describes compounds of formula I, which are useful in the treatment of diseases where inhibition of leukotriene C synthase is desired. The compounds, along with their pharmaceutically-acceptable salts, are particularly effective in treating respiratory diseases and inflammation.
Career Highlights
Schaal is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to work on groundbreaking research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Wesley Ralph Schaal collaborates with Carl Jonas Lindh, contributing to the advancement of pharmaceutical research and development. Their partnership exemplifies the importance of teamwork in the innovation process.
Conclusion
Wesley Ralph Schaal's contributions to pharmaceutical innovations highlight his commitment to improving health outcomes through targeted therapies. His work continues to influence the field and offers hope for effective treatments for respiratory diseases and inflammation.